Evidence map›Paper›PMID 34977932›Full record

ArticleHealth policy and planning2022

Addressing severe chronic NCDs across Africa: measuring demand for the Package of Essential Non-communicable Disease Interventions-Plus (PEN-Plus).

Chantelle Boudreaux, Prebo Barango, Alma Adler, Patrick Kabore, Amy McLaughlin, Mohamed Ould Sidi Mohamed, Paul H Park, Steven Shongwe, Jean Marie Dangou, Gene Bukhman

Open access · hybridAbstract read
In one paragraph

Article in Health policy and planning, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Observational
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Chantelle BoudreauxDepartment of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Avenue, Boston, MA 02115, USA.ORCID 0000-0001-9776-8523
Prebo BarangoWHO Regional Office for Africa, Cité de Djoué, Brazzaville, Republic of Congo.
Alma AdlerDivision of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
Patrick KaboreWHO Regional Office for Africa, Cité de Djoué, Brazzaville, Republic of Congo.
Amy McLaughlinNCD Synergies Project, Partners in Health, Maryland County, Liberia.
Mohamed Ould Sidi MohamedWHO Regional Office for Africa, Cité de Djoué, Brazzaville, Republic of Congo.
Paul H ParkDepartment of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Avenue, Boston, MA 02115, USA.
Steven ShongweWHO Regional Office for Africa, Cité de Djoué, Brazzaville, Republic of Congo.
Jean Marie DangouWHO Regional Office for Africa, Cité de Djoué, Brazzaville, Republic of Congo.
Gene BukhmanDepartment of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Avenue, Boston, MA 02115, USA.
World Health Organization Regional Office for Africa · CGBrigham and Women's Hospital · USHarvard University · USPartners In Health · US

Funding

Leona M. and Harry B. Helmsley Charitable TrustWorld Health Organization 001
6 · The paper itself

Abstract

Severe chronic non-communicable diseases (NCDs) pose important challenges for health systems across Africa. This study explores the current availability of and demand for decentralization of services for four high-priority conditions: insulin-dependent diabetes, heart failure, sickle cell disease, and chronic pain. Ministry of Health NCD Programme Managers from across Africa (N = 47) were invited to participate in an online survey. Respondents were asked to report the status of clinical care across the health system. A care package including diagnostics and treatment was described for each condition. Respondents were asked whether the described services are currently available at primary, secondary and tertiary levels, and whether making the service generally available at that level is expected to be a priority in the coming 5 years. Thirty-seven (79%) countries responded. Countries reported widespread gaps in service availability at all levels. We found that just under half (49%) of respondents report that services for insulin-dependent diabetes are generally available at the secondary level (district hospital); 32% report the same for heart failure, 27% for chronic pain and 14% for sickle cell disease. Reported gaps are smaller at tertiary level (referral hospital) and larger at primary care level (health centres). Respondents report ambitious plans to introduce and decentralize these services in the coming 5 years. Respondents from 32 countries (86%) hope to make all services available at tertiary hospitals, and 21 countries (57%) expect to make all services available at secondary facilities. These priorities align with the Package of Essential NCD Interventions-Plus. Efforts will require strengthened infrastructure and supply chains, capacity building for staff and new monitoring and evaluation systems for efficient implementation. Many countries will need targeted financial assistance in order to realize these goals. Nearly all (36/37) respondents request technical assistance to organize services for severe chronic NCDs.

Indexed as

Anemia, Sickle CellChronic PainDiabetes MellitusHeart FailureNoncommunicable DiseasesChronic DiseaseHumansInsulinPrimary Health CareInsulinAccesscardiovascular diseasedecentralizationhealth care planningnon-communicable diseasepalliative carepolicypriorities

Identifiers

PMID34977932
PMCPMC9006066
OpenAlexW4206457919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.